Literature DB >> 27663027

Adaptation of Akkermansia muciniphila to the Oxic-Anoxic Interface of the Mucus Layer.

Janneke P Ouwerkerk1, Kees C H van der Ark1, Mark Davids2, Nico J Claassens1, Teresa Robert Finestra1, Willem M de Vos1,3,4, Clara Belzer5.   

Abstract

Akkermansia muciniphila colonizes the mucus layer of the gastrointestinal tract, where the organism can be exposed to the oxygen that diffuses from epithelial cells. To understand how A. muciniphila is able to survive and grow at this oxic-anoxic interface, its oxygen tolerance and response and reduction capacities were studied. A. muciniphila was found to be oxygen tolerant. On top of this, under aerated conditions, A. muciniphila showed significant oxygen reduction capacities and its growth rate and yield were increased compared to those seen under strict anaerobic conditions. Transcriptome analysis revealed an initial oxygen stress response upon exposure to oxygen. Thereafter, genes related to respiration were expressed, including those coding for the cytochrome bd complex, which can function as a terminal oxidase. The functionality of A. muciniphila cytochrome bd genes was proven by successfully complementing cytochrome-deficient Escherichia coli strain ECOM4. We conclude that A. muciniphila can use oxygen when it is present at nanomolar concentrations.IMPORTANCE This article explains how Akkermansia muciniphila, previously described as a strictly anaerobic bacterium, is able to tolerate and even benefit from low levels of oxygen. Interestingly, we measured growth enhancement of A. muciniphila and changes in metabolism as a result of the oxygen exposure. In this article, we discuss similarities and differences of this oxygen-responsive mechanism with respect to those of other intestinal anaerobic isolates. Taken together, we think that these are valuable data that indicate how anaerobic intestinal colonizing bacteria can exploit low levels of oxygen present in the mucus layer and that our results have direct relevance for applicability, as addition of low oxygen concentrations could benefit the in vitro growth of certain anaerobic organisms.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Year:  2016        PMID: 27663027      PMCID: PMC5103097          DOI: 10.1128/AEM.01641-16

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  40 in total

1.  Anoxic media design, preparation, and considerations.

Authors:  Caroline M Plugge
Journal:  Methods Enzymol       Date:  2005       Impact factor: 1.600

2.  Fast gapped-read alignment with Bowtie 2.

Authors:  Ben Langmead; Steven L Salzberg
Journal:  Nat Methods       Date:  2012-03-04       Impact factor: 28.547

3.  Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology.

Authors:  Maria Carlota Dao; Amandine Everard; Judith Aron-Wisnewsky; Nataliya Sokolovska; Edi Prifti; Eric O Verger; Brandon D Kayser; Florence Levenez; Julien Chilloux; Lesley Hoyles; Marc-Emmanuel Dumas; Salwa W Rizkalla; Joel Doré; Patrice D Cani; Karine Clément
Journal:  Gut       Date:  2015-06-22       Impact factor: 23.059

4.  Mucosal flora in inflammatory bowel disease.

Authors:  Alexander Swidsinski; Axel Ladhoff; Annelie Pernthaler; Sonja Swidsinski; Vera Loening-Baucke; Marianne Ortner; Jutta Weber; Uwe Hoffmann; Stefan Schreiber; Manfred Dietel; Herbert Lochs
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

5.  Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium.

Authors:  Muriel Derrien; Elaine E Vaughan; Caroline M Plugge; Willem M de Vos
Journal:  Int J Syst Evol Microbiol       Date:  2004-09       Impact factor: 2.747

6.  Interaction of bd-type quinol oxidase from Escherichia coli and carbon monoxide: heme d binds CO with high affinity.

Authors:  V B Borisov
Journal:  Biochemistry (Mosc)       Date:  2008-01       Impact factor: 2.487

7.  The strict anaerobe Bacteroides fragilis grows in and benefits from nanomolar concentrations of oxygen.

Authors:  Anthony D Baughn; Michael H Malamy
Journal:  Nature       Date:  2004-01-29       Impact factor: 49.962

8.  Akkermansia muciniphila Adheres to Enterocytes and Strengthens the Integrity of the Epithelial Cell Layer.

Authors:  Justus Reunanen; Veera Kainulainen; Laura Huuskonen; Noora Ottman; Clara Belzer; Heikki Huhtinen; Willem M de Vos; Reetta Satokari
Journal:  Appl Environ Microbiol       Date:  2015-03-20       Impact factor: 4.792

9.  1,3-Propanediol production from glycerol by a newly isolated Trichococcus strain.

Authors:  Antonie H van Gelder; Rozelin Aydin; M Madalena Alves; Alfons J M Stams
Journal:  Microb Biotechnol       Date:  2011-11-24       Impact factor: 5.813

10.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.

Authors:  Mark D Robinson; Davis J McCarthy; Gordon K Smyth
Journal:  Bioinformatics       Date:  2009-11-11       Impact factor: 6.937

View more
  35 in total

1.  Nanaerobic growth enables direct visualization of dynamic cellular processes in human gut symbionts.

Authors:  Leonor García-Bayona; Michael J Coyne; Noam Hantman; Paula Montero-Llopis; Salena S Von; Takeshi Ito; Michael H Malamy; Marek Basler; Blanca Barquera; Laurie E Comstock
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-16       Impact factor: 11.205

2.  Altitudinal variation of the gut microbiota in wild house mice.

Authors:  Taichi A Suzuki; Felipe M Martins; Michael W Nachman
Journal:  Mol Ecol       Date:  2018-11-15       Impact factor: 6.185

3.  Genotypic and Phenotypic Diversity among Human Isolates of Akkermansia muciniphila.

Authors:  Bradford Becken; Lauren Davey; Dustin R Middleton; Katherine D Mueller; Agastya Sharma; Zachary C Holmes; Eric Dallow; Brenna Remick; Gregory M Barton; Lawrence A David; Jessica R McCann; Sarah C Armstrong; Per Malkus; Raphael H Valdivia
Journal:  mBio       Date:  2021-05-18       Impact factor: 7.867

Review 4.  Safety of Novel Microbes for Human Consumption: Practical Examples of Assessment in the European Union.

Authors:  Theodor Brodmann; Akihito Endo; Miguel Gueimonde; Gabriel Vinderola; Wolfgang Kneifel; Willem M de Vos; Seppo Salminen; Carlos Gómez-Gallego
Journal:  Front Microbiol       Date:  2017-09-12       Impact factor: 5.640

Review 5.  Intestinal microbiome landscaping: insight in community assemblage and implications for microbial modulation strategies.

Authors:  Sudarshan A Shetty; Floor Hugenholtz; Leo Lahti; Hauke Smidt; Willem M de Vos
Journal:  FEMS Microbiol Rev       Date:  2017-03-01       Impact factor: 16.408

6.  Complete Genome Sequence of Akkermansia glycaniphila Strain PytT, a Mucin-Degrading Specialist of the Reticulated Python Gut.

Authors:  Janneke P Ouwerkerk; Jasper J Koehorst; Peter J Schaap; Jarmo Ritari; Lars Paulin; Clara Belzer; Willem M de Vos
Journal:  Genome Announc       Date:  2017-01-05

7.  Deciphering the trophic interaction between Akkermansia muciniphila and the butyrogenic gut commensal Anaerostipes caccae using a metatranscriptomic approach.

Authors:  Loo Wee Chia; Bastian V H Hornung; Steven Aalvink; Peter J Schaap; Willem M de Vos; Jan Knol; Clara Belzer
Journal:  Antonie Van Leeuwenhoek       Date:  2018-02-19       Impact factor: 2.271

Review 8.  The interaction of Akkermansia muciniphila with host-derived substances, bacteria and diets.

Authors:  Tatsuro Hagi; Clara Belzer
Journal:  Appl Microbiol Biotechnol       Date:  2021-06-14       Impact factor: 4.813

Review 9.  Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila.

Authors:  Patrice D Cani; Willem M de Vos
Journal:  Front Microbiol       Date:  2017-09-22       Impact factor: 5.640

10.  Model-driven design of a minimal medium for Akkermansia muciniphila confirms mucus adaptation.

Authors:  Kees C H van der Ark; Steven Aalvink; Maria Suarez-Diez; Peter J Schaap; Willem M de Vos; Clara Belzer
Journal:  Microb Biotechnol       Date:  2018-01-26       Impact factor: 5.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.